Flintkote Medical Requirements and Evidence Required to Establish an Asbestos-Related Disease for Individual Review Claimants
Level I: Asbestosis/Pleural Disease
Medical Criteria
- Diagnosis of a bilateral asbestos-related non-malignant disease based upon either:
- A physical exam of the claimant by the physician providing the diagnosis, or
- If the claimant is deceased at the time the claim was filed, pathological evidence of the non-malignant asbestos-related disease.
- Evidence of a bilateral asbestos-related non-malignant disease based upon:
- A chest x-ray read by a certified B-reader of 1/0 or higher1; or
- A chest x-ray read by a certified B-reader or read by a qualified physician2, or
- A CAT scan read by a qualified physician2, or
- A pathology report, in each case, showing bilateral interstitial fibrosis, bilateral pleural plaques, bilateral pleural thickening, or bilateral pleural calcification.
- 10 year latency.
Exposure Criteria
- Six months Flintkote exposure prior to December 31, 1982, and
- Five years cumulative occupational exposure to asbestos.
Level II: Asbestosis/Pleural Disease
Medical Criteria
- Diagnosis of a bilateral asbestos-related non-malignant disease based upon either:
- A physical exam of the claimant by the physician providing the diagnosis, or
- If the claimant is deceased at the time the claim was filed, pathological evidence of the non-malignant asbestos-related disease.
- Evidence of a bilateral asbestos-related non-malignant disease based upon:
- A chest x-ray read by a certified B-reader of 1/0 or higher1; or
- A chest x-ray read by a certified B-reader or read by a qualified physician2, or
- A CAT scan read by a qualified physician2, or
- A pathology report, in each case, showing bilateral interstitial fibrosis, bilateral pleural plaques, bilateral pleural thickening, or bilateral pleural calcification.
- Pulmonary Function Testing with either:
- A TLC less than 80%, or
- FVC less than 80% and FEV1/FVC ratio greater than or equal to 65%, or
- Pulmonary Function Test must be in compliance with the quality criteria established by the ATS3.
- 10 year latency.
- Supporting medical documentation establishing asbestos exposure as a contributing factor in causing the pulmonary disease.
Exposure Criteria
- Six months Flintkote Exposure prior to December 31, 1982, and
- Significant Occupational Exposure4 to asbestos.
Level III: Severe Asbestosis
Medical Criteria
- Diagnosis of an asbestosis based upon either:
- A physical exam of the claimant by the physician providing the diagnosis, or
- If the claimant is deceased at the time the claim was filed, pathological evidence of the non-malignant asbestos-related disease.
- An ILO of 2/1 or greater, or
- Pathological evidence of asbestosis.
- Pulmonary Function Testing with either:
- A TLC less than 65%, or
- FVC less than 65% and FEV1/FVC ratio greater than 65%, or
- Pulmonary Function Test must be in compliance with the quality criteria established by the ATS3.
- 10 year latency.
- Supporting medical documentation establishing asbestos exposure as a contributing factor in causing the pulmonary disease.
Exposure Criteria
- Six months of Flintkote Exposure prior to December 31, 1982, and
- Significant Occupational Exposure4 to asbestos.
Level IV: Other Cancer
Medical Criteria
- A diagnosis of a primary colo-rectal, laryngeal, esophageal, pharyngeal, or stomach cancer based upon either:
- A physical exam of the claimant by the physician providing the diagnosis of the asbestos related disease, or
- A diagnosis of such a malignant disease by a board-certified pathologist or by a pathology report prepared at or on behalf of a JCAHO accredited hospital.
- Evidence of an underlying bilateral asbestos-related non-malignant disease based upon:
- A chest x-ray read by a certified B-reader of 1/0 or higher1, or
- A chest x-ray read by a certified B-reader or read by a qualified physician2, or
- A CAT scan read by a qualified physician2, or
- A pathology report, in each case, showing bilateral interstitial fibrosis, bilateral pleural plaques, bilateral pleural thickening, or bilateral pleural calcification.
- A causal statement from a medical doctor linking the other cancer in question to asbestos exposure.
- 10 year latency.
Exposure Criteria
- Six months of Flintkote Exposure prior to December 31, 1982, and
- Significant Occupational Exposure4 to asbestos.
Level V: Lung Cancer 2
Medical Criteria
- A diagnosis of a primary lung based upon either
- A physical exam of the claimant by the physician providing the diagnosis of the asbestos related disease, or
- A diagnosis of such a malignant disease by a board-certified pathologist or by a pathology report prepared at or on behalf of a JCAHO accredited hospital.
- A causal statement from a medical doctor linking the other cancer in question to asbestos exposure.
- 10 year latency.
Exposure Criteria
- Flintkote Exposure prior to December 31, 1982
*Lung Cancer 2 (Level V) claims are claims that do not meet the medical and/or exposure criteria of Lung Cancer 1 (Level VI). All claims with this Disease Level will be individually evaluated.
There is no distinction between non-smokers and smokers for either Lung Cancer 1 (level VI) or Lung Cancer 2 (level V). A claimant who meets the requirements of Lung Cancer 1, and is a non-smoker may wish to have his or her claim individually evaluated by the Trust.
Level VI: Lung Cancer 1
Medical Criteria
- A diagnosis of a primary lung cancer based upon either:
- A physical exam of the claimant by the physician providing the diagnosis of the asbestos related disease, or
- A diagnosis of such a malignant disease by a board-certified pathologist, or by a pathology report prepared at or on behalf of a JCAHO accredited hospital.
- Evidence of an underlying bilateral asbestos-related non-malignant disease based upon:
- A chest x-ray read by a certified B-reader of 1/0 or higher1, or
- A chest x-ray read by a certified B-reader or other qualified physician2, or
- A CAT scan read by a qualified physician2, or
- A pathology report, in each case showing bilateral interstitial fibrosis, bilateral pleural plaques, bilateral pleural thickening, or bilateral pleural calcification.
- A causal statement from a medical doctor linking the lung cancer to asbestos exposure.
- 10 year latency.
Exposure Criteria
- Six months of Flintkote Exposure prior to December 31, 1982, and
- Significant Occupational Exposure4 to asbestos.
Level VII: Mesothelioma
Medical Criteria
- A diagnosis of mesothelioma based upon either
- A physical exam of the claimant by a physician providing the diagnosis of the asbestos related disease, or
- A diagnosis of such a malignant disease level by a board-certified pathologist or by a pathology report prepared at or on behalf of a JCAHO accredited hospital.
- 10 year latency
Exposure Criteria
- Flintkote Exposure as defined in Section 5.7(b)(3) of the TDP prior to December 31, 1982.
Note: A finding by a physician after the Effective Date that a claimant’s disease is “consistent with” or “compatible with” asbestosis will not alone be treated by the Trust as a diagnosis.
1For claims filed before the petition date, if an ILO reading is not available, then Flintkote will accept a chest x-ray report (read by a Qualified Physician) regardless of whether it was read by a qualified B-reader.
2Qualified Physician – Physician board-certified in a specialized field of medicine, such as pulmonology, radiology, internal medicine, or occupational medicine.
3ATS – American Thoracic Society.
4Significant Occupational Exposure – Employment for a cumulative period of at least five years with a minimum of two years prior to December 31, 1982 in an industry and an occupation in which the claimant:
A. handled raw asbestos fibers on a regular basis;
B. fabricated asbestos-containing products so that the claimant in the fabrication process was exposed on a regular basis to raw asbestos fibers;
C. altered, repaired or otherwise worked with asbestos-containing products such that the claimant was exposed on a regular basis to asbestos fibers;
D. was employed in an industry and occupation such that the claimant worked on a regular basis in close proximity to workers engaged in the activities described in (a), (b) and/or (c).